Immunotherapy combined with chemotherapy

DRUG3 trials

Sponsors

RenJi Hospital, Longhao Li, Affiliated Hospital of Nantong University

Conditions

Neoadjuvant Therapy of Locally Advanced Upper Urinary Tract Urothelial CarcinomaRectal AdenocarcinomaTriple Negative Breast Cancer (TNBC)

Phase 2

Neoadjuvant PD-1 Monoclonal Antibody Plus Cisplatin-based Chemotherapy in Locally Advanced Upper Tract Urothelial Carcinoma

RenJi HospitalNeoadjuvant Therapy of Locally Advanced Upper Urinary Tract Urothelial Carcinoma

Start: 2020-12-10End: 2022-06-01Updated: 2020-12-17

Involve-site Radiotherapy Combined With Chemotherapy and Immunotherapy as Neoadjuvant Treatment for Locally Advanced Rectal Cancer

Not yet recruitingNCT07161115

Longhao LiRectal Adenocarcinoma

Start: 2025-09-19End: 2030-08-31Target: 60Updated: 2025-09-15

QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Triple-Negative Breast Cancer

RecruitingNCT07342283

Affiliated Hospital of Nantong UniversityTriple Negative Breast Cancer (TNBC)

Start: 2026-02-25End: 2028-12-25Target: 30Updated: 2026-03-02